Product Name | YLQPRTFLL |
Product Quantity | 4mg |
Catalog Number | LT8263 |
Category | SARS2_Spike |
Sequence | YLQPRTFLL |
Purity | >95% |
Product Description | The YLQPRTFLL peptide corresponds to the S269Ð277 epitope of the SARS-CoV-2 spike protein. Presented by HLA-A*02:01, it is recognized by CD8+ T cells and is a target for immune responses in COVID-19 patients. This epitope is significant in studies of T cell immunity, vaccine design, and understanding the adaptive immune response to SARS-CoV-2. |
Scientific Background | YLQPRTFLL is a 9-residue synthetic peptide with the sequence Tyr-Leu-Gln-Pro-Arg-Thr-Phe-Leu-Leu. The sequence has a relatively high hydrophobic-residue fraction that can influence aqueous solubility and surface adsorption. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence. |
Research Applications | - LC-MS/HPLC analytical method development
- sequence-specific assay controls
|
Experimental Notes | Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions. |
